Accelerating Medicines Partnership Type 2 Diabetes
GPTKB entity
Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:research
|
| gptkbp:aimsTo |
identify and validate biological targets for Type 2 diabetes
|
| gptkbp:collaboratorsInclude |
gptkb:National_Institutes_of_Health
non-profit organizations pharmaceutical companies |
| gptkbp:focusesOn |
gptkb:Type_2_diabetes
|
| gptkbp:partOf |
gptkb:Accelerating_Medicines_Partnership
|
| gptkbp:startYear |
2018
|
| gptkbp:website |
https://fnih.org/our-programs/AMP/AMP-T2D
|
| gptkbp:bfsParent |
gptkb:AMP_Type_2_Diabetes
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Accelerating Medicines Partnership Type 2 Diabetes
|